Targeting macrophage-mediated tumor cell phagocytosis: An overview of phagocytosis checkpoints blockade, nanomedicine intervention, and engineered CAR-macrophage therapy.

Moradinasab, Susan; Pourbagheri-Sigaroodi, Atieh; Ghaffari, Seyed H; Bashash, Davood

Moradinasab, Susan; Pourbagheri-Sigaroodi, Atieh; Ghaffari, Seyed H; Bashash, Davood.

Afiliação

Moradinasab S; Iranian Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Pourbagheri-Sigaroodi A; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Ghaffari SH; Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Bashash D; Department of Hematology and Blood Banking, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: D.bashash@sbmu.ac.ir.

Int Immunopharmacol ; 103: 108499, 2022 Feb.

Article em En | MEDLINE | ID: mdl-34972068

Assuntos

Nanomedicina; Neoplasias; Citofagocitose; Humanos; Imunoterapia; Macrófagos; Fagocitose

Palavras-chave

CAR-macrophage; Immunotherapy; Nanomedicine; Phagocytosis Checkpoints Blockade; Tumor-associated Macrophage

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanomedicina / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanomedicina / Neoplasias Idioma: En Ano de publicação: 2022 Tipo de documento: Article